CIRM Clinical Dashboard
Funding Clinical Trials
Our Agency funds clinical trials testing promising stem cell-based treatments for currently incurable diseases or disorders to help patients with unmet medical needs. For basic information about stem cell trials, visit our Clinical Trials 101 page. For a list of clinical trials that are a result of early-stage CIRM grants click here.
CIRM Clinical Dashboard
Disease Areas |
Investigator | Organization | Phase | Trial Status | Targeted Enrollment | Detail |
|---|---|---|---|---|---|---|
| Howard Foyt | ViaCyte, Inc. | Phase 1/2 | Closed | 19 | ||
| William Sietsema | Caladrius Biosciences | Phase 2 | Completed | 113 | ||
| Manasi Jaiman | ViaCyte, Inc. | Phase 1/2 | Active, not recruiting | 75 | ||
| Peter Stock | University of California, San Francisco | Phase 1/2 | Recruiting | 8 |
